INOVIO PHARMACEUTICALS, INC. Contract Liability (Deferred Revenue)
INOVIO PHARMACEUTICALS, INC. (INO) had Contract Liability (Deferred Revenue) of $0 as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2023-03-01
- 2022-12-31: Contract with Customer, Liability, Current $0.00.
- 2022-09-30: Contract with Customer, Liability, Current $0.00.
- 2022-06-30: Contract with Customer, Liability, Current $8.98M.
- 2022-03-31: Contract with Customer, Liability, Current $15.38K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-01 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $8.98M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $15.38K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $21.63K 10-K · filed 2023-03-01 |
| 2021-09-30 | $77.88K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $109.13K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $15.38K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $46.63K 10-K · filed 2022-03-01 |
| 2020-09-30 | $77.88K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $14.85K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $67.27K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $92.35K 10-K · filed 2021-03-01 |
| 2019-09-30 | $106.11K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $120.69K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $110.69K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $223.58K 10-K · filed 2020-03-12 |
| 2018-09-30 | $192.43K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $762.36K 10-Q · filed 2018-08-07 |
| 2017-12-31 | $1.18M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |